An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries.

•Americans spend more on primary care pharmaceuticals than residents of comparable countries.•Higher spending in the USA is not driven by higher utilization.•Americans spend more because of higher prices and more expensive treatment choices.•Achieving outcomes in comparable countries would save Americans over $21 billion annually.